Acer Therapeutics Inc. (NASDAQ:ACER – Get Free Report) shares crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.81 and traded as high as $0.85. Acer Therapeutics shares last traded at $0.66, with a volume of 574,600 shares changing hands. Wall […]
Acer Therapeutics (NASDAQ:ACER – Get Free Report) issued its quarterly earnings results on Monday. The biopharmaceutical company reported ($0.53) EPS for the quarter, missing analysts’ consensus estimates of ($0.13) by ($0.40), reports. The firm had revenue of $0.37 million during the quarter, compared to analysts’ expectations of $2.55 million. Acer Therapeutics Stock Down 17.9 % […]
Short Interest in Acer Therapeutics Inc. (NASDAQ:ACER) Declines By 41.1% themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Acer Therapeutics Inc. (NASDAQ:ACER – Get Free Report) was the recipient of a significant decrease in short interest during the month of September. As of September 30th, there was short interest totalling 529,100 shares, a decrease of 41.1% from the September 15th total of 898,100 shares. Based on an average daily trading volume, of 2,300,000 […]
HC Wainwright cut shares of Acer Therapeutics (NASDAQ:ACER – Free Report) from a buy rating to a neutral rating in a research report released on Tuesday morning, Marketbeat reports. HC Wainwright also issued estimates for Acer Therapeutics’ Q3 2023 earnings at ($0.12) EPS, Q4 2023 earnings at ($0.06) EPS and FY2024 earnings at $0.00 EPS. […]